Events | December 07, 2021
Oncologists call for adoption of tech innovations to treat cancer
The event was organized jointly by Oncology Forum and Fortis Cancer Institute, Delhi NCR
The event was organized jointly by Oncology Forum and Fortis Cancer Institute, Delhi NCR
The facility will supply clinical trial materials for the development of vaccines and biologics up to Phase II stage and is expected to be fully operational by early 2023.
It works with Pfizer to support more rapid innovation and improved clinical manufacturing operations to help develop tomorrow’s therapies
Transaction adds to Sanofi pipeline a potential first-in-class vaccine candidate in acne vulgaris, a condition affecting millions of people worldwide
She replaces Victoria Tabiner, who is stepping down after 10 years at Sygnature
ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio
The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector
The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation
Subscribe To Our Newsletter & Stay Updated
